It’s unusual for a lawyer to get indicted along with his client. But the key thing here is Shkreli wasn’t Greebel’s client. Greebel was lead outside counsel for Retrophin, the pharma company where Shkreli was chief executive from 2012 to 2014. He is accused of crossing the line by papering deals that benefited Shkreli at the expense of his real clients, Retrophin’s shareholders.
‘Enforcement 40’ for 2020
Join Us On LinkedIn
Join the Securities Litigation and Enforcement Group on LinkedIn